OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunological and clinical implications of immune checkpoint blockade in human cancer
Hyung‐Don Kim, Su‐Hyung Park
Archives of Pharmacal Research (2019) Vol. 42, Iss. 7, pp. 567-581
Closed Access | Times Cited: 18
Hyung‐Don Kim, Su‐Hyung Park
Archives of Pharmacal Research (2019) Vol. 42, Iss. 7, pp. 567-581
Closed Access | Times Cited: 18
Showing 18 citing articles:
Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications
Inseong Jung, Sanghee Shin, Moon‐Chang Baek, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 19-31
Open Access | Times Cited: 46
Inseong Jung, Sanghee Shin, Moon‐Chang Baek, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 19-31
Open Access | Times Cited: 46
Enhancing CAR T-cell therapy through cellular imaging and radiotherapy
Il Minn, Steven P. Rowe, Martin G. Pomper
The Lancet Oncology (2019) Vol. 20, Iss. 8, pp. e443-e451
Closed Access | Times Cited: 78
Il Minn, Steven P. Rowe, Martin G. Pomper
The Lancet Oncology (2019) Vol. 20, Iss. 8, pp. e443-e451
Closed Access | Times Cited: 78
Immune checkpoints and cancer development: Therapeutic implications and future directions
Saber Mehdizadeh, Hashem Bayatipoor, Salar Pashangzadeh, et al.
Pathology - Research and Practice (2021) Vol. 223, pp. 153485-153485
Closed Access | Times Cited: 43
Saber Mehdizadeh, Hashem Bayatipoor, Salar Pashangzadeh, et al.
Pathology - Research and Practice (2021) Vol. 223, pp. 153485-153485
Closed Access | Times Cited: 43
Engineering an active immunotherapy for personalized cancer treatment and prevention of recurrence
Kerui Wu, Feng Lyu, Shih-Ying Wu, et al.
Science Advances (2023) Vol. 9, Iss. 17
Open Access | Times Cited: 14
Kerui Wu, Feng Lyu, Shih-Ying Wu, et al.
Science Advances (2023) Vol. 9, Iss. 17
Open Access | Times Cited: 14
Immunotherapy in Gynecologic Cancers: What We Know Now and Where We Are Headed
Kimberly Levinson, Oliver Dorigo, Krista M. Rubin, et al.
American Society of Clinical Oncology Educational Book (2019), Iss. 39, pp. e126-e140
Closed Access | Times Cited: 36
Kimberly Levinson, Oliver Dorigo, Krista M. Rubin, et al.
American Society of Clinical Oncology Educational Book (2019), Iss. 39, pp. e126-e140
Closed Access | Times Cited: 36
Implication of CD69+CD103+ tissue‐resident‐like CD8+ T cells as a potential immunotherapeutic target for cholangiocarcinoma
Hyung‐Don Kim, Seongju Jeong, Seongyeol Park, et al.
Liver International (2021) Vol. 41, Iss. 4, pp. 764-776
Closed Access | Times Cited: 29
Hyung‐Don Kim, Seongju Jeong, Seongyeol Park, et al.
Liver International (2021) Vol. 41, Iss. 4, pp. 764-776
Closed Access | Times Cited: 29
The landscape and prognostic value of tumor-infiltrating immune cells in gastric cancer
Linhai Li, Yiming Ouyang, Wenrong Wang, et al.
PeerJ (2019) Vol. 7, pp. e7993-e7993
Open Access | Times Cited: 26
Linhai Li, Yiming Ouyang, Wenrong Wang, et al.
PeerJ (2019) Vol. 7, pp. e7993-e7993
Open Access | Times Cited: 26
Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant
Michael Fichtner, Emir Bozkurt, Manuela Salvucci, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 23
Michael Fichtner, Emir Bozkurt, Manuela Salvucci, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 23
Advances in Immunotherapy and Periocular Malignancy
Larissa A. Habib, Natalie Wolkow, Suzanne K. Freitag, et al.
Seminars in Ophthalmology (2019) Vol. 34, Iss. 4, pp. 327-333
Closed Access | Times Cited: 15
Larissa A. Habib, Natalie Wolkow, Suzanne K. Freitag, et al.
Seminars in Ophthalmology (2019) Vol. 34, Iss. 4, pp. 327-333
Closed Access | Times Cited: 15
A Metastatic Intrahepatic Cholangiocarcinoma Treated with Programmed Cell Death 1 Inhibitor: A Case Report and Literature Review
Jingjing Zhang, Lihua Wu, Jian Liu, et al.
Immunotherapy (2020) Vol. 12, Iss. 8, pp. 555-561
Closed Access | Times Cited: 13
Jingjing Zhang, Lihua Wu, Jian Liu, et al.
Immunotherapy (2020) Vol. 12, Iss. 8, pp. 555-561
Closed Access | Times Cited: 13
CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies
Lucía Aragón-Serrano, Laura Carrillo‐Serradell, Violeta Planells-Romeo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17510-17510
Open Access | Times Cited: 4
Lucía Aragón-Serrano, Laura Carrillo‐Serradell, Violeta Planells-Romeo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17510-17510
Open Access | Times Cited: 4
Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report
Keiko Inakami, Noriko Fujita, Chikage Iguchi, et al.
Journal of Medical Case Reports (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Keiko Inakami, Noriko Fujita, Chikage Iguchi, et al.
Journal of Medical Case Reports (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Setting the Dose of Checkpoint Inhibitors: The Role of Clinical Pharmacology
Étienne Chatelut, Félicien Le Louedec, G. Milano
Clinical Pharmacokinetics (2019) Vol. 59, Iss. 3, pp. 287-296
Closed Access | Times Cited: 9
Étienne Chatelut, Félicien Le Louedec, G. Milano
Clinical Pharmacokinetics (2019) Vol. 59, Iss. 3, pp. 287-296
Closed Access | Times Cited: 9
Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report
Katsuya Toshida, Shinji Itoh, Tomoharu Yoshizumi, et al.
Clinical Journal of Gastroenterology (2021) Vol. 14, Iss. 5, pp. 1459-1463
Closed Access | Times Cited: 8
Katsuya Toshida, Shinji Itoh, Tomoharu Yoshizumi, et al.
Clinical Journal of Gastroenterology (2021) Vol. 14, Iss. 5, pp. 1459-1463
Closed Access | Times Cited: 8
A model based on tumor-infiltrating immune cells for predicting the relapse rates of patients with testicular germ cell tumors
Yichun Wang, Chengjian Ji, Jinhui Liu, et al.
International Immunopharmacology (2020) Vol. 86, pp. 106710-106710
Closed Access | Times Cited: 5
Yichun Wang, Chengjian Ji, Jinhui Liu, et al.
International Immunopharmacology (2020) Vol. 86, pp. 106710-106710
Closed Access | Times Cited: 5
[Progress of Steroids Effect on Efficacy of Immune Checkpoint Inhibitors].
Guoqiang Pan, Yun Fan
DOAJ (DOAJ: Directory of Open Access Journals) (2019) Vol. 22, Iss. 12, pp. 786-793
Closed Access | Times Cited: 1
Guoqiang Pan, Yun Fan
DOAJ (DOAJ: Directory of Open Access Journals) (2019) Vol. 22, Iss. 12, pp. 786-793
Closed Access | Times Cited: 1
Immunotherapy in patients with cervical cancer
А. Г. Кедрова
Tumors of female reproductive system (2020) Vol. 16, Iss. 2, pp. 72-77
Open Access
А. Г. Кедрова
Tumors of female reproductive system (2020) Vol. 16, Iss. 2, pp. 72-77
Open Access
Progress of PD-1/PD-L1 Inhibitors in the Treatment of Esophageal Cancer
艳利 张
Advances in Clinical Medicine (2022) Vol. 12, Iss. 06, pp. 5222-5229
Closed Access
艳利 张
Advances in Clinical Medicine (2022) Vol. 12, Iss. 06, pp. 5222-5229
Closed Access
